Claim Missing Document
Check
Articles

Found 2 Documents
Search

COMPARISON OF PAIN PERCEPTION BETWEEN INTRAVENA TRAMADOL INJECTION WITH PERIPROSTATIC LIDOCAINE INJECTION IN TRANSRECTAL ULTRASONOGRAPHY GUIDED PROSTATE BIOPSY PATIENT Sawal, Zuhri; Djatisoesanto, Wahjoe; Djojodimedjo, Tarmono
Indonesian Journal of Urology Vol 27 No 2 (2020)
Publisher : Indonesian Urological Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32421/juri.v27i2.646

Abstract

Objective: To compare the pain perception between intravenous tramadol administration and PNB technique using lidocaine in TRUS guided prostate biopsy. Material & Methods: The design of this study is a prospective randomized clinical trial. The population of this study is BPH patients who will undergo TRUS guided prostate biopsy procedure according to the indication in our center. Randomization was done for the determination of groups 1 and 2. Group 1 was given tramadol injection 100 mg intravenously, while group 2 was given a local injection of lidocaine periprostatic. The Wong-Baker scale directly determined pain perception during the procedure. Results: The total samples in this study were 20 samples that met the inclusion and exclusion criteria with 10 samples in each group. The lidocaine group had a lower Wong Baker’s pain scale in both probe USG insertion and prostate biopsy than the tramadol group. However, it’s not statistically significant (p=0.089; p=0.125, respectively). Conclusion: The use of intravenous tramadol can be used as an alternative anesthetic/analgesic method in prostate biopsy patients. The pain scale of the intravenous tramadol can be compared with periprostatic lidocaine with lesser complications compared to periprostatic lidocaine.
Impact of Stone Size, Location, and Stone Composition on the Efficacy of Extracorporeal Shock Wave Lithotripsy for Residual Stone after Percutaneous Nephrolithotomy Sawal, Zuhri; Soebadi, Doddy M
Folia Medica Indonesiana Vol. 56, No. 2
Publisher : Folia Medica Indonesiana

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

This study aimed to determine the impact of stone size, location and stone composition the efficacy of extracorporeal shock wave lithotripsy (ESWL) in the management of residual stone after percutaneous nephrolithotomy (PCNL). The design of this study was a retrospective that conducted between January 2012 until December 2016. The population in this study were all patients with residual stones post PCNL. Exclusion criteria were patients with multiple stones and patients with a history of previous treatment for residual stones such as nephroscopy, flexible ureterorenoscopy, ESWL or medical therapy). The variables studied in this study were stone size, stone location, and stone composition. Before ESWL was carried out, all patients underwent Kidney Ureter Bladder (KUB). After ESWL, all patients underwent ultrasonography (USG) and KUB to determine the stone clearance status. The sample of this study was 125 patients. The overall stone-free rate (SFR) of ESWL in managing post-PCNL residual stones is 72%. SFR based on stone size variable are 73.7% and 71.3% respectively for stones with a size = 5 mm and >5 mm (p = 0.78). SFR based on stone location variable was 67.1%, 75.8%, and 81.8% respectively for the residual stone located at the upper pole, middle pole and lower pole. There are no significant differences in the entire variable. This study concludes that ESWL can be used as effective additional management to treat post-PCNL residual stones with satisfactory SFR.